• DAF-2 diacetate: Reliable NO Assay Workflows

  2026-09-09

  Learn how DAF-2 diacetate, SKU C4210, supports reproducible live-cell nitric oxide imaging alongside viability and cytotoxicity assays. This scenario-based guide covers probe chemistry, protocol design, storage, interpretation, vendor selection, and limitations when translating NO measurements across experimental systems.

• ARCA EGFP mRNA for Transfection Control

  2026-09-09

  ARCA EGFP mRNA provides a fast, direct fluorescence readout for comparing transfection conditions, cell models, and nanoparticle formulations. Its ARCA cap and optimized poly(A) tail make it especially useful as an mRNA transfection control before advancing to therapeutic payloads.

• HotStart Universal 2X Green qPCR Master Mix Workflow

  2026-09-08

  Build reproducible real-time PCR gene expression analysis around apoptotic extracellular vesicle signaling in lung adenocarcinoma. This workflow combines hot-start specificity, universal ROX normalization, and melt curve analysis for specificity with practical controls for SOX2, ALDH1A1, stemness, and metastasis studies.

• RNA Clean and Concentrator Kit: Assay-Ready IVT RNA

  2026-09-07

  The RNA Clean and Concentrator Kit is more than a cleanup step: it defines the quality of IVT RNA entering functional assays and LNP workflows. This guide connects RNA purification spin column design with p21 mRNA delivery research, assay controls, and translational limitations.

• TAI-1 Hec1 Inhibitor Workflows for Cancer Research

  2026-09-07

  TAI-1 provides a practical route to study Hec1-dependent mitotic failure, cancer cell proliferation inhibition, and apoptotic cell death induction. This workflow connects robust phenotyping with a newer replication-stress framework, helping researchers distinguish direct mitotic effects from secondary DNA-damage responses.

• ARCA EGFP mRNA: Reliable Assay Controls

  2026-09-05

  Learn how ARCA EGFP mRNA, SKU R1001, helps laboratories separate transfection performance from viability and cytotoxicity effects. This scenario-based guide covers reporter selection, protocol handling, data interpretation, and practical vendor evaluation for mammalian cell assays.

• Trelagliptin succinate: Applied Research Workflows

  2026-09-04

  Build a practical research workflow around Trelagliptin succinate, from nanomolar DPP-4 enzyme inhibition to adipocyte glucose-uptake assays and signaling analysis. The guide translates reference findings into assay-ready decisions, troubleshooting checkpoints, and cautious extensions into metabolic, bone, and cognitive research.

• Mutant Branching Enzyme Improves Pea Starch Function

  2026-09-04

  A 2026 study used structure-guided mutagenesis to improve a 1,4-α-glucan branching enzyme from Bifidobacterium longum for pea-starch modification. The best-performing S321D variant altered starch branching, reduced retrogradation, slowed in vitro digestion, and improved the texture and digestive profile of pea cake.

• Ro 3306 as a Temporal Probe of DNA Repair

  2026-09-04

  Ro 3306 is a selective CDK1 inhibitor that converts cell-cycle timing into an experimental variable for interpreting DNA repair and cancer studies. This article explains how to pair CDK1-controlled synchronization with TopBP1, BRCA1, and RAD51 assays without confusing cell-cycle effects with direct pathway inhibition.

• BAPTA-AM: Practical Calcium Chelation Guide

  2026-09-03

  BAPTA-AM is a cell-permeable calcium chelator for experimentally lowering free intracellular Ca²⁺ in cellular and biochemical assays. It is useful for calcium-signaling, apoptosis, and imaging workflows, but should not be interpreted as a calcium-only reagent because it can also block voltage-gated potassium channels and may show magnesium-related interference.

• One-step TUNEL FITC Apoptosis Detection Kit Workflow

  2026-09-02

  Build a reproducible FITC-based DNA fragmentation assay for pulmonary vascular remodeling studies, with practical workflows for tissue sections, adherent cells, suspension cells, microscopy, and flow cytometry. The guide shows how to use TUNEL positivity as a focused cell-death endpoint alongside pathway, proliferation, and metabolic readouts.

• GET3–MCL1 Tail-Anchoring Links Mitosis to Apoptosis

  2026-09-02

  Yu and colleagues identify GET3 as a membrane-targeting factor that stabilizes the anti-apoptotic protein MCL1 through its C-terminal tail anchor. Their findings connect GET3-dependent protein targeting with mitotic fate, showing that GET3 loss lowers MCL1 abundance and sensitizes cells to apoptosis during prolonged mitotic arrest or pharmacological MCL1 inhibition.

• 5-Aminolevulinic acid HCl: Heme Flux to Translation

  2026-09-01

  A mechanistic analysis of how 5-Aminolevulinic acid HCl can connect heme-pathway research with cancer and infection models. Building on a recent Salmonella study, this article outlines a disciplined strategy for using pathway perturbation, porphyrin readouts, and macrophage phenotyping without overstating translational maturity.

• Maternal IL-17A and Neonatal GBS Risk

  2026-09-01

  A prospective Moroccan mother–newborn study identifies reduced maternal IL-17A, IL-1β, and IL-4 responses as features associated with invasive neonatal Group B Streptococcus disease. Its combination of clinical cytokine profiling, cord-blood analysis, and ex vivo pathogen-recognition receptor stimulation supports maternal IL-17A as a candidate biomarker for neonatal risk stratification, while also defining important limits for validation.

• Cimetidine for BBB and Cancer Research

  2026-08-31

  Cimetidine can serve as both an H2 receptor signaling probe and an exploratory compound in high-throughput barrier assays. This workflow combines careful solution preparation with bidirectional transport, recovery analysis, and lysosomal-trapping controls to distinguish exposure effects from genuine permeability mechanisms.

8649 records 1/577 page Next 12345 下5页 Last page